Fundz

Rarity PBC Raises $4.6 Million Seed Financing to Advance Gene Therapy for ADA-SCID, led by Steve Oliveira from Nemean Asset Management.

PRIVATEOct 29, 2025

Amount Raised

$4.6 Million

Round Type

Seed

Los AngelesBiotechnologyHealth Care

Investors

Nemean Asset ManagementSteve Oliveira

Description

Rarity PBC has successfully closed a $4.6 million seed financing round aimed at accelerating the development of their gene therapy for ADA-SCID. The funding was led by biotech investor Steve Oliveira. Proceeds will support efforts towards establishing commercial-grade manufacturing and gaining FDA approval. Rarity aims to ensure all children with ADA-SCID can access the therapy.

Quick answer

Rarity PBC raised $4.6 Million in a Seed round, dated October 29, 2025. Investors: Nemean Asset Management and Steve Oliveira. Rarity PBC is based in Los Angeles, California, United States.

How much did Rarity PBC raise?
Rarity PBC raised $4.6 Million in a Seed round on October 29, 2025.
Who invested in Rarity PBC?
Nemean Asset Management and Steve Oliveira are named as investors in this round.
What does Rarity PBC do?
Rarity PBC is a Public Benefit Corporation focused on expanding access to transformative gene therapies for rare diseases.
Where is Rarity PBC based and how big is it?
Rarity PBC is based in Los Angeles, California, United States. Fundz records about 5 employees.
Who are the decision-makers at Rarity PBC?
Fundz holds 1 contact at Rarity PBC. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Rarity PBC that raised within 45 days of this round, from Fundz verified event records.

  • Enveric Biosciences raised $107K on December 12, 2025.
  • OXOS Medical raised $11M on December 12, 2025.
  • Prolynx raised $70M (Series A) on December 11, 2025.
  • Allegria Therapeutics raised $5.1M (Seed) on December 11, 2025.
  • Subsense raised $10M (Funding Round) on December 11, 2025.
  • Disco Pharmaceuticals raised $42M (Seed) on December 11, 2025.

Who to call at Rarity PBC, and when

A new round usually means Rarity PBC is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Rarity PBC raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rarity PBC, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rarity PBC. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rarity PBC

Location

Los Angeles, California, United States

About

Rarity PBC is a Public Benefit Corporation focused on expanding access to transformative gene therapies for rare diseases. The company is dedicated to developing a one-time autologous hematopoietic stem cell gene therapy for adenosine deaminase severe combined immunodeficiency (ADA-SCID). Rarity aims to merge clinical validation with a public benefit mandate to enhance treatment access for patients. The team collaborates closely with researchers from UCLA to bring innovative therapies to market.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rarity PBC raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Rarity PBC's next move

See what Strategic adds

Rarity PBC raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.